Results 61 to 70 of about 4,665 (160)

Magnetically Recoverable ICT-Functionalized Fe₃O₄ Nanoparticles for Efficient Horseradish Peroxidase Immobilization. [PDF]

Molecules
Isaković K, Jonović M, Sredojević D, Bošković M, Periša J, Knežević-Jugović Z, Lazić V.   +6 more
europepmc   +1 more source

Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid. [PDF]

Inflamm Bowel Dis
Yarur A, Irving P, Siegmund B, Dubinsky MC, Ananthakrishnan AN, Regueiro M, Ungaro RC, Ritter T, Nakase H, Liu Z, Mehra D, Osterman MT, Jain A, Rubin DT, Hibi T.   +14 more
europepmc   +1 more source

Study on the role of the combination of quercetin and lutein in alleviating ulcerative colitis in mice. [PDF]

Front Nutr
Xu Z, Mi S, Chitrakar B, Wang L, Li Y, Shi R, Sang Y, Yu W, Wang X.   +8 more
europepmc   +1 more source

Mirikizumab: a landmark in IL-23-targeted therapy for ulcerative colitis. [PDF]

Ann Med Surg (Lond)
Iqbal MU, Shafquat E, Khan MO, Abu Nahla U.   +3 more
europepmc   +1 more source

Current and emerging therapies for pulmonary tuberculosis in adults. [PDF]

BMJ Med
Mahmood A, Ashfaq MB, Drain C, Melby E, Hunter M, Shaw TD.   +5 more
europepmc   +1 more source

Emerging Role of Gut Microbiota in Modulating Response to Therapies in IBD. [PDF]

Microorganisms
Bartocci B, Del Gaudio A, Murgiano M, Papa A, Cammarota G, Gasbarrini A, Scaldaferri F, Lopetuso LR.   +7 more
europepmc   +1 more source

Drug Exposure Dictates Evolutionary Dynamics of Drug-Resistant Tuberculosis: A Longitudinal Cohort Study in Beijing, China. [PDF]

Infect Drug Resist
Wen S, Li H, Shi Y, Wei R, Ge F, Pang Y, Liu Y.   +6 more
europepmc   +1 more source

Significant kidney impairment in pediatric inflammatory bowel disease and practice points for pediatric gastroenterologists. [PDF]

J Pediatr Gastroenterol Nutr
Vuijk SA, Klomberg RCW, Schwerd T, Griffiths AM, Hussey S, Carroll MW, Malmborg P, Deb P, Wessels M, Mouratidou N, van Biervliet S, Friedt M, Minson S, Vrieling-Prince FHM, Croft NM, de Ridder L, PIBD‐SETQuality Safety Registry Collaborative Group.   +16 more
europepmc   +1 more source

A Comprehensive Review of Genetic Mechanisms of <i>Mycobacterium tuberculosis</i> Resistance to Injectable Agents, Second-Line Drugs, and Novel Therapeutics. [PDF]

Infect Drug Resist
Roshdi Maleki M.
europepmc   +1 more source

Navigating a thorny path: oral nanomedicines for the precision management of radiation-induced intestinal injury. [PDF]

J Nanobiotechnology
Yu B, Zhang J, Tang Y, Zou Y, Xu H, Yang M, Xu K, Yu J, Miao YB, Du X.   +9 more
europepmc   +1 more source